home | Hanmi Pharmaceutical co., ltd.

Products Search

Product Search

1. Quantum project: R&D No.1 Bio new drug for diabetes (Quantum project)|Next generation targeted oncology|26 new drug pipelines
2. Contribute to human health: Dedication to promote human health | Hanmi Pharmaceutical devotes to promote human health and to serve corporate social responsibility.

News Centermore

Hanmi Pharmaceutical Group to establish venture capital firm ‘Hanmi Ventures’ Jul 14, 2016
Hanmi Science acquires JVM''s major shareholder 's stake. Jun 17, 2016
Hanmi presented the research results of long acting diabetes-obesity medicines at ADA. Jun 17, 2016
Hanmi presented the clinical trial results of two targeted anti-ancer drugs at ASCO. Jun 17, 2016
Boehringer Ingelheim launches ambitious ELUXA trial programme to broadly investigate promising lung cancer compound olmutinib. Jun 15, 2016

Highlightsmore

Promotional videoHanmi Pharmaceuticals is a Korea-based global pharmaceutical company focused on the development and commercialization of new pharmaceutical products

R&D

Quantum Project

Quantum leap of anti-diabetes/obesity theatment throug LAPSCOVERY biobetters weekly Insulin, weekly GLP-1, and weeklt Combo
LAPSCOVERY

Novel platform technology for biologics, Long Acting Protein / Peptide Discovery
NCE Discovery

Next generation targeted oncology, autoimmune & metabolic diseases

Global Products

Hanmi at a glance

No 1. R&D Company for global new drug development

Business development

Dedicated to develop and provide innovative, valuable drugs for its customers

Compliance program

Compliance system and code of conduct